Milbar Recalls MD Complete Clarifying Cleanser Due to GMP Deviations
Milbar Laboratories is voluntarily recalling 14,491 tubes of MD Complete Clarifying Cleanser due to Good Manufacturing Practice (GMP) deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations. The hazard is related to GMP deviations, which is a quality control issue rather than a direct, reported health threat, fitting the criteria for a moderate severity score.
Plain-English summary
Milbar Laboratories, Inc. is voluntarily recalling 14,491 tubes of MD Complete Clarifying Cleanser (Salicylic Acid 2.0%), 3 fl oz. The product is manufactured by Milbar Laboratories, Inc. and distributed by MD Professional LLC in Minneapolis, MN. The recall was initiated on May 4, 2018, and was classified as Class II by the FDA.
The reason for the recall is Good Manufacturing Practice (GMP) deviations. The affected products are identified by Lot numbers KU503-6 and KU393-6, with an expiration date of 12/28/2020. The product was distributed within the United States and Puerto Rico.
Consumers who have this product should stop using it and contact the recalling firm for instructions on how to return the product or obtain a refund. The recall was terminated on June 26, 2019.
The recalled product
- Product
- MD Complete Clarifying Cleanser (Salicylic Acid 2.0%), 3 fl oz, (88.7mL), MD Professional LLC, Minneapolis, MN
- Manufacturer
- Milbar Laboratories, Inc.
- Category
- Drug — Topical Skin Care
- Hazard
- Affected units
- 14,491
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: KU503-6
- KU393-6
- Exp. 12/28/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 4 recalled by Milbar Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Milbar Laboratories, Inc.
See all →- ModerateMilbar Recalls Willa Clear Skin Salicylic Acid Tubes Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Willa Pore Perfector Pads Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls DCL SA Scalp Therapy Shampoo Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Malin + Goetz Salicylic Gel Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls DCL Alpha Beta Gel Toner Due to GMP Deviations
FDA (Drugs) · 2020-11-25
Same hazard · gmp deviation
See all →- HighPrazosin hydrochloride tablets recalled over nitrosamine impurity above limits
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride further lots recalled over nitrosamine impurity levels
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride 100-count bottles recalled over nitrosamine impurity
FDA (Drugs) · 2026-04-08
- ModerateFirst Aid Only hand sanitizing wipes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11
- ModerateFirst Aid Only BZK antiseptic towelettes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11